In Times of Rate Hikes, Industrial Metals Rise Fastest
Source: Tom Beck for The Gold Report  (5/22/17)
Tom Beck, senior editor of Portfolio Wealth Global, says in times of rate hikes, industrial metals rise fastest, and in today's world, the type of metals in highest demand by China are going to rise the most. More >

The Marijuana Sector: Timing the Next Upleg
Source: Clive Maund for Streetwise Reports  (5/21/17)
Canadian and U.S. marijuana stocks have taken divergent paths over the last six months, and technical analyst Clive Maund examines why. More >

Jack Chan’s Weekly Gold and Silver Market Update: The Correction Continues
Source: Jack Chan for The Gold Report  (5/20/17)
Technical analyst Jack Chan charts the latest moves in the precious metals market, noting a price bounce off positive divergence.
More >

Energy's Day in the Sun Is Coming for Investors
Source: The Energy Report  (5/18/17)
Market trends are aligning in energy's favor, says Louis James, editor of International Speculator, and in this interview with The Energy Report, he discusses several segments of the market that he believes could see large gains. More >

Don't Waver—Hard Asset Bull Market Still Intact
Source: The Gold Report  (5/18/17)
The severity of the commodities bear market from 2011–2015 makes Matt Geiger, managing partner at MJG Capital, confident that the current hard asset bull market will last into 2019 and quite possibly longer. In this interview with The Gold Report, Geiger discusses commodities he is especially keen on right now and several companies that he expects to perform well. More >

Is the Market Plunge Just a Storm in a Teacup?
Source: Clive Maund for The Gold Report  (5/18/17)
Technical analyst Clive Maund analyzes Wednesday's drop in U.S. stock markets amid concerns over political turmoil in Washington. More >

Sunesis Pharmaceuticals Shifts Focus to Leukemia Drug
Source: The Life Sciences Report  (5/17/17)
In light of a decision to pull its application for approval of vosaroxin in the European Union, Sunesis Pharmaceuticals has designated its BTK inhibitor program targeting chronic lymphocytic leukemia as its new lead program. More >

Inovio Moves Forward on Brain Cancer and Cancers Caused by HPV; Zika and Ebola Vaccines Also Advance
Source: The Life Sciences Report  (5/17/17)
Inovio Pharmaceuticals' pipeline of vaccine and immunotherapeutic products is advancing steadily through the phases of development, with a host of milestones anticipated in 2017, including the start of a Phase 3 trial in cervical dysplasia and the initiation of trials with partners in brain cancer and cancers caused by human papillomavirus. In this interview with The Life Sciences Report, Inovio President and CEO, Dr. J. Joseph Kim, walks investors through the promising possibilities, and also provides updates on its vaccines for the Zika, MERS and Ebola viruses. More >

Big Pharma Sets Its Sights on NASH Epidemic
Source: The Life Sciences Report  (5/17/17)
Up to one-third of Americans may have conditions that lead to NASH, yet the disease is far from a household name. Closely linked with obesity, the disease does not become symptomatic until very late stage. Ed Arce, managing director in equity research and a senior analyst covering companies in the biopharmaceuticals and specialty pharmaceuticals sectors for H.C. Wainwright, organized the recent inaugural NASH Investor Conference. In part one of his interview with The Life Sciences Report, Arce discusses the disease, its market potential and how companies large and small are trying to fix the current dearth of treatments. More >

Two Ways to Beat the Odds with Mining Investing
Source: The Gold Report  (5/17/17)
Gold has been trading sideways for a while, but that does not perturb Louis James, editor of the International Speculator. In this interview with The Gold Report, James explains why the he is comfortable with the current gold price and discusses his two investments theses for precious metals. More >

Keith Neumeyer Just Emailed Me: 'This Is My Core Zinc Position'
Source: Lior Gantz for The Gold Report  (5/17/17)
Keith Neumeyer, who built his career in silver and precious metals, is diversifying into industrial metals, specifically zinc, says Lior Gantz, editor of Wealth Research Group. More >

LiCo Energy Metals Seeks Energy Metals
Source: Bob Moriarty for The Energy Report  (5/15/17)
With solar energy on the ascendance, Bob Moriarty of 321 Energy discusses LiCo Energy Metals and its lithium and cobalt projects. More >

Tinka Resources: Ayawilca Could Grow into a World-Class Zinc Asset
Source: The Critical Investor for The Gold Report  (5/15/17)
The Critical Investor examines Tinka Resources, which has found high levels of zinc in the first holes of a new exploration program. More >

Investors Are Pulling Out of US Stocks
Source: Tom Beck for The Gold Report  (5/14/17)
Tom Beck of Portfolio Wealth Global discusses why he believes the U.S. stock market has peaked and what factors could reignite gold stocks. More >

Jack Chan’s Weekly Gold and Silver Market Update: A Selloff in Silver
Source: Jack Chan for The Gold Report  (5/13/17)
Technical analyst Jack Chan charts the latest moves in the precious metal markets, noting the impacts of a sharp selloff in silver. More >

Yields Over 8% Are Still Attractive
Source: Adrian Day for The Gold Report  (5/12/17)
Money manager Adrian Day discusses several business development companies in his portfolio that offer high dividends. More >

Pan American Silver Tops CIBC's Silver Producer List
Source: The Gold Report  (5/12/17)
Pan American Silver released Q1 earnings of $20 million, and CIBC reaffirmed the company's position as its top silver producer pick. More >

IAMGOLD's Gross Profit Increases 438% in Q1
Source: The Gold Report  (5/12/17)
Among the Q1/17 financial results that IAMGOLD released were a 12% increase in gold production and a 438% gain in gross profits. More >

Analysts View Franco-Nevada's Q1 Earnings as Strong Start to 2017
Source: The Gold Report  (5/11/17)
Franco-Nevada's Q1/17 earnings beat expectations and analysts say the company is off to a good start in 2017. More >

Sandstorm Gold's Mariana Acquisition Is Focus for Analysts
Source: The Gold Report  (5/11/17)
The first quarter results for Sandstorm Gold are in and the focus for analysts is on the agreement to acquire Mariana Resources. More >

DURECT and Sandoz Ink $293 Million Deal for POSIMIR
Source: The Life Sciences Report  (5/10/17)
DURECT Corp. and Sandoz AG, a division of Novartis, have signed a development and commercialization agreement for the U.S. for POSIMIR. More >

3D Signatures' Platform Taps into the Power of the Genome
Source: The Life Sciences Report  (5/10/17)
How fast is my cancer progressing? Does this treatment present my best option for a cure? These two big questions, which determine outcomes for patients with serious diseases such as Hodgkin's lymphoma, prostate cancer and Alzheimer's disease, are addressed by the platform technology in development by 3D Signatures Inc. In this interview with The Life Sciences Report, 3DS's new Chief Scientific Officer, Dr. Kevin Little, describes the TeloView platform, its utility in the marketplace and what makes it a compelling investment. More >

Drilling Extends Strike at TerraX's Yellowknife City Project
Source: The Gold Report  (5/9/17)
The assay results that TerraX released give it plenty of targets to follow up with at its Yellowknife City Gold Project. More >

When Will Gold Stocks Take Off?
Source: Tom Beck for The Gold Report  (5/8/17)
Gold stocks are trading at valuations not seen in decades, according to Tom Beck, senior editor of Portfolio Wealth Global. But conditions are ideal for a new gold bull.
More >

Millennium Minerals, Searching for a Greater Fool
Source: Bob Moriarty for The Gold Report  (5/8/17)
Precious metals expert Bob Moriarty updates investors on recent moves by Millennium Minerals in Australia and discusses recent moves in the silver COT reports. More >